Mid-weight oncology stocks: The dark horses of cancer research
18 No. of Symbols
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.98 USD
−160.81 M USD
0.00 USD
34.33 M
About ALX Oncology Holdings Inc.
Sector
Industry
CEO
Jason Lettmann
Website
Headquarters
South San Francisco
Founded
2015
FIGI
BBG00VR8SDG8
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ALXO is featured.
Frequently Asked Questions
The current price of ALXO is 1.55 USD — it has increased by 12.16% in the past 24 hours. Watch ALX Oncology Holdings Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ALX Oncology Holdings Inc. stocks are traded under the ticker ALXO.
ALXO stock has risen by 16.08% compared to the previous week, the month change is a 17.73% rise, over the last year ALX Oncology Holdings Inc. has showed a −80.60% decrease.
We've gathered analysts' opinions on ALX Oncology Holdings Inc. future price: according to them, ALXO price has a max estimate of 25.00 USD and a min estimate of 3.00 USD. Watch ALXO chart and read a more detailed ALX Oncology Holdings Inc. stock forecast: see what analysts think of ALX Oncology Holdings Inc. and suggest that you do with its stocks.
ALXO reached its all-time high on Dec 10, 2020 with the price of 117.45 USD, and its all-time low was 1.19 USD and was reached on Nov 19, 2024. View more price dynamics on ALXO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALXO stock is 17.15% volatile and has beta coefficient of 2.19. Track ALX Oncology Holdings Inc. stock price on the chart and check out the list of the most volatile stocks — is ALX Oncology Holdings Inc. there?
Yes, you can track ALX Oncology Holdings Inc. financials in yearly and quarterly reports right on TradingView.
ALX Oncology Holdings Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ALXO earnings for the last quarter are −0.58 USD per share, whereas the estimation was −0.78 USD resulting in a 25.64% surprise. The estimated earnings for the next quarter are −0.67 USD per share. See more details about ALX Oncology Holdings Inc. earnings.
ALX Oncology Holdings Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ALXO net income for the last quarter is −30.71 M USD, while the quarter before that showed −39.40 M USD of net income which accounts for 22.06% change. Track more ALX Oncology Holdings Inc. financial stats to get the full picture.
No, ALXO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 4, 2024, the company has 72.00 employees. See our rating of the largest employees — is ALX Oncology Holdings Inc. on this list?
Like other stocks, ALXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALX Oncology Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALX Oncology Holdings Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALX Oncology Holdings Inc. stock shows the sell signal. See more of ALX Oncology Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.